GREY:IPHAF - Post by User
Post by
singlebogeyon Jan 23, 2009 2:37am
551 Views
Post# 15722984
canadian society of transplantation conference Mar
canadian society of transplantation conference MarCanadian Society of Transplantation conference March 09. Final results of the PROMISE 2B extension trail: an abstract will be presented . Abstract title is... Voclosporin (ISA247) Demonstrates a reduced risk of metabolic syndrome after transplantation: Results from the phase 2b PROMISE extension trial.
Here is the link, the abstract title is listed on page 8.
https://www.cst-transplant.ca/cmsUploads/cst/File/2009_Final_Program_Dec16.pdf
comments?